GCT-66. FINAL REPORT OF THE PROSPECTIVE NEXT/CNS-GCT-4 CONSORTIUM TRIAL (GemPOx FOLLOWED BY MARROW-ABLATIVE CHEMOTHERAPY) IN PATIENTS WITH REFRACTORY/RECURRENT CNS GERM CELL TUMORS

BACKGROUND: We report the responses, toxicities and long-term outcomes of gemcitabine, paclitaxel and oxaliplatin (GemPOx) regimen administered, in responsive patients, prior to single cycle marrow-ablative chemotherapy (thiotepa, etoposide and carboplatin) with autologous hematopoietic progenitor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shatara, Margaret, Blue, Megan, Stanek, Joseph R, Liu, Allison Y, Osorio, Diana S, AbdelBaki, Mohamed S, Prevedello, Daniel, Puduvalli, Vinay, Giglio, Pierre, Gardner, Sharon, Allen, Jeffrey, Wong, Kenneth E, Dhall, Girish, Finlay, Jonathan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Germ Cell Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715238/
http://dx.doi.org/10.1093/neuonc/noaa222.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715238/
http://dx.doi.org/10.1093/neuonc/noaa222.283

Ejemplares similares